Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HANOVER INSURANCE GROUP, INC.THG · Entity 3652 | Director · President and CEO | September 25, 2026 | September 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HANOVER INSURANCE GROUP, INC.
Report date September 25, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 141,253.034 |
Reported balance
After 2026-09-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-25 · Grant · Acquired 120.052 · Balance 141,253.034 F1: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2: Does not include 14,454 shares held by the Reporting Person's spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.
F2: Does not include 14,454 shares held by the Reporting Person's spouse.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 28, 2026 20:24 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 120.052 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-405374 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,253.034 F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:10 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 122.234 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-290508 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,132.982 F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 61 | $194.77 | $11,880.97 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · nonDerivative · entry 6 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,010.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 5,145 | $194.05 | $998,387.25 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · nonDerivative · entry 5 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,071.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $193.73 to $194.72. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 3,152 | $193.21 | $608,997.92 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · nonDerivative · entry 4 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,216.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $192.70 to $193.69. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 24,026 | $0.00 Strike: $104.11 | $0.00 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · derivative · entry 8 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,052 Underlying: Common Stock · 24,026 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 72,078 shares, vested 1/3 on each of 2/27/19, 2/27/20 and 2/27/21. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 9,098 | $0.00 Strike: $85.87 | $0.00 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · derivative · entry 7 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,098 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 27,292 shares, vested 1/3 on each of 2/24/18, 2/24/19 and 2/24/20. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Tax withholdingCommon Stock | 24,766 | $193.79 | $4,799,403.14 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,368.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 24,026 | $104.11 | $2,501,346.86 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 174,134.748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:26 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 9,098 | $85.87 | $781,245.26 |
DisclosureSEC source: 0001428157-26-000005 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,108.748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 100 | $199.23 | $19,923.00 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · nonDerivative · entry 6 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,010.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 12,943 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 5,251 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 2,516 | $198.65 | $499,803.40 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · nonDerivative · entry 5 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,110.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 12,943 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 5,251 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $198.19 to $199.11. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 2,260 | $197.61 | $446,598.60 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · nonDerivative · entry 4 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,626.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 12,943 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 5,251 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $197.07 to $198.06. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 375 | $196.55 | $73,706.25 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,886.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 12,943 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 5,251 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $196.07 to $197.04. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 18,194 | $0.00 Strike: $85.87 | $0.00 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · derivative · entry 7 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,098 Underlying: Common Stock · 18,194 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 27,292 shares, vested 1/3 on each of 2/24/18, 2/24/19 and 2/24/20. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Tax withholdingCommon Stock | 12,943 | $194.64 | $2,519,225.52 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,261.748 F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 12,943 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 5,251 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:32 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 18,194 | $85.87 | $1,562,318.78 |
DisclosureSEC source: 0001428157-26-000002 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159,204.748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 12,943 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 5,251 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 20:08 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 152.574 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-134537 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,010.748 F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:45 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Tax withholdingCommon Stock | 14,220 | $180.63 | $2,568,558.60 |
DisclosureSEC source: 0001193125-26-086045 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,858.174 F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 27, 2026. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:42 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock Option (right to buy) · Derivative | 45,025 | $0.00 Strike: $173.56 | $0.00 |
DisclosureSEC source: 0001193125-26-076977 · ownership.xml · derivative · entry 4 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,025 Underlying: Common Stock · 45,025 shares Expires 2036-02-24 F5 · derivative.exercise_date: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:42 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 9,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-076977 · ownership.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,078.174 F4 · kind: Grant of restricted stock units under the Issuer's 2022 LTIP. Such units vest on the third anniversary of the date of grant. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:42 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 8,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-076977 · ownership.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,643.174 F3 · kind: On February 27, 2023, the Reporting Person was granted PBRSUs pursuant to the Issuer's 2022 LTIP. These PBRSUs were subject to a performance-based vesting condition related to three-year relative total shareholder return and a time-based vesting condition, and also provided for the accumulation of dividend equivalent rights. On February 24, 2026, the performance condition for this award was certified at 100% of the target award (as adjusted for accumulated dividend equivalent rights). This award remains subject to the time-based vesting condition and will vest on February 27, 2026. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:42 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 13,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-076977 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,103.174 F1 · kind: On February 27, 2023, the Reporting Person was granted performance-based restricted stock units ("PBRSUs") pursuant to the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP"). These PBRSUs were subject to a performance-based vesting condition related to three-year average adjusted return on equity and a time-based vesting condition, and also provided for the accumulation of dividend equivalent rights. On February 24, 2026, the performance condition for this award was certified at 150% of the target award (as adjusted for accumulated dividend equivalent rights). This award remains subject to the time-based vesting condition and will vest on February 27, 2026. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| December 26, 2025 Filed Dec 29, 2025 21:15 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 134.535 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-335364 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,849.174 F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:10 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Tax withholdingCommon Stock | 382 | $185.91 | $71,017.62 |
DisclosureSEC source: 0001193125-25-306684 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,714.639 F1 · kind: Reflects shares withheld from restricted stock unit awards to cover FICA and related income tax obligations for executives eligible for retirement vesting under the terms of such awards. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 21:29 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GiftCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-269714 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,096.639 F1 · kind: Charitable gift of shares. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| September 26, 2025 Filed Sep 30, 2025 20:19 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 132.183 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-225073 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,686.639 F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| June 27, 2025 Filed Jun 30, 2025 20:55 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 140.748 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091682 · ownership.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,554.456 F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:11 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 8,906 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0001062993-25-006823 · form4.xml · derivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,906 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:11 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 8,906 | $175.17 | $1,560,064.02 |
DisclosureSEC source: 0001062993-25-006823 · form4.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,413.708 F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $175 to $175.83. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:11 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 8,906 | $77.91 | $693,866.46 |
DisclosureSEC source: 0001062993-25-006823 · form4.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,319.708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 301 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · derivative · entry 7 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,906 Underlying: Common Stock · 301 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 301 | $175.00 | $52,675.00 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 5 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,413.708 F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 301 | $77.91 | $23,450.91 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 4 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,714.708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · derivative · entry 6 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,207 Underlying: Common Stock · 400 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock | 135.857 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,413.708 F3 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 400 | $175.03 | $70,012.00 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,277.851 F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 20:06 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 400 | $77.91 | $31,164.00 |
DisclosureSEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,677.851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 20:17 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 200 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0001062993-25-006497 · form4.xml · derivative · entry 6 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,607 Underlying: Common Stock · 200 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 20:17 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 200 | $175.01 | $35,002.00 |
DisclosureSEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 4 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,277.851 F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $175 to $175.01. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 20:17 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 200 | $77.91 | $15,582.00 |
DisclosureSEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,477.851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:17 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 900 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0001062993-25-006497 · form4.xml · derivative · entry 5 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,807 Underlying: Common Stock · 900 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:17 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 900 | $175.17 | $157,653.00 |
DisclosureSEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,277.851 F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $175 to $175.27. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:17 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 900 | $77.91 | $70,119.00 |
DisclosureSEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,177.851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:27 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock Option (right to buy) · Derivative | 10,706 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0001062993-25-004321 · form4.xml · derivative · entry 5 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,707 Underlying: Common Stock · 10,706 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:27 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 5,509 | $172.66 | $951,183.94 |
DisclosureSEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 4 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,277.851 F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $172.35 to $173.31. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:27 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 3,303 | $171.86 | $567,653.58 |
DisclosureSEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,786.851 F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $171.34 to $172.34. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:27 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | SaleCommon Stock | 1,894 | $170.91 | $323,703.54 |
DisclosureSEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 2 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,089.851 F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $170.33 to $171.33. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:27 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Exercise / conversionCommon Stock | 10,706 | $77.91 | $834,104.46 |
DisclosureSEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 1 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,983.851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:21 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | Tax withholdingCommon Stock | 8,826 | $170.53 | $1,505,097.78 |
DisclosureSEC source: 0001062993-25-004106 · form4.xml · nonDerivative · entry 3 Roche John C · CIK 0001428157 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,277.851 F3 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement. F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.